Simple Moving Averages
Before looking at the financial values or the trading statistics of TG Therapeutics, Inc. (TGTX), we will start our analysis with the SMA or Simple Moving Average values.
The SMA or Simple Moving Averages are commonly available for 20 Day, 50 Day and 200 Day Simple Moving Averages. For our stock under consideration here, TG Therapeutics, Inc. (TGTX) has distance from 20 Day SMA is -6.37% while its distance from 50 day SMA is -0.86%. TGTX’s distance from 200 Day SMA is 42.16%.
While looking at the SMA values of TG Therapeutics, Inc. (TGTX), the 200 simple moving average (SMA) is considered a key indicator by traders and market analysts for determining the overall long-term trend. The 200 SMA is considered so critically important a trend indicator that the event of the 50-day SMA crossing to the downside of the 200-day SMA is referred to as a death cross, signaling a serious bear market in a stock, index or other investment.
Last Trading Day Performance
On the last trading day, TG Therapeutics, Inc. (TGTX) gained 0.45% closing at the price of $11.1 while the previous close of TGTX was $11.05.
TG Therapeutics, Inc. (TGTX) traded with the volume of 5.79 Million shares while its average 3 months volume is at 1710 shares.
TG Therapeutics, Inc. (TGTX) has a market capitalization of 737.93 Million while its Major Index membership is at 0.
Shares of TG Therapeutics, Inc. (TGTX) touched the day high at $11.45 while its day Low was at $10.90. In contrast, TGTX’s 52 week high hovers at $15.35 with its current distance from 52 week high value is -27.69%. TG Therapeutics, Inc. (TGTX) 52 week low value is at $4.10 and its current distance from 52 week low value is 170.73%.
Volatility of the shares is also to be considered while making the investment decisions. As volatility place a very vital role in identifying the risk involved in the particular case. In our current pick, TG Therapeutics, Inc. (TGTX) has weekly volatility of 7.90%% while its monthly volatility value is at 7.81%%.
Another indicator of risk for a particular security is “Beta”. A beta approximates the overall volatility of a security’s returns against the returns of a relevant benchmark (usually the S&P 500 is used). Currently TG Therapeutics, Inc. (TGTX) has beta value of 1.2. This Beta value of TG Therapeutics, Inc. (TGTX) shows that it has historically moved 120% for every 100% move in the benchmark.
For making investment decisions, Financial Ratios play a vital role. There is a large variety of Financial Ratios that can be considered while making an investment decision but here in the case of TG Therapeutics, Inc. (TGTX), we will discuss a few.
Annual Dividend Yield of TG Therapeutics, Inc. (TGTX) stands at 0%.
Price to Earning P/E ratio and Forward P/E stand at 0 and 0 respectively.
TG Therapeutics, Inc.’s Quick Ratio shows the value of 6.
Debt to Equity ratio stands at 0 while Long Term Debt To Equity Ratio flashes the value of 0.